FDA’s Marks admonishes U.K. regulators for discussing COVID vaccine adverse events as MHRA updates guidance

FDA’s Peter Marks has criticized U.K. regulators for releasing incomplete information about serious adverse events experienced by two individuals following administration of the BNT162b2 COVID-19 vaccine from Pfizer and BioNTech. MHRA updated its guidance to include new details about the management of anaphylaxis.

Marks’ comments come on a day that also saw news of a security breach at EMA and Canada’s first approval of a COVID-19 vaccine...